Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024

1
Cancer Diagnostics Market Global Industry
Trends and Forecast to 2024
Global Cancer Diagnostics Market By Technology
(ELISA, ELFA, PCR, NGS, Immunohistochemistry,
Microarray, Imaging (MRI, CT, PET, Ultrasound,
Mammography), Biopsy), By Application (Breast
Cancer, Lung Cancer, Colorectal Cancer,
Melonoma), By Geography (North America, Europe,
Asia-Pacific, Latin America, Rest of the World)
Trends and Forecast to 2024
Browse Full Report and Details TOC
http//databridgemarketresearch.com/reports/global
-cancer-diagnostics-market/
2
Report Description
Global Cancer Diagnostics Market is expected to
reach USD 18.4 billion by 2024 from USD 7.6
billion in 2016, at a CAGR of 11.7 in the
forecast period 2017 to 2024.The new market
report contains data for historic years 2014
2015, the base year of calculation is 2016 and
the forecast period is 2017 to 2024. Key factors
propelling growth of this market are
technological advancements in the diagnostics
imaging systems, growing number of cancer
patients globally, rapidly aging population, and
huge government support for research in cancer
diagnostics.
Request Sample Report http//databridgemarketre
search.com/request-a-sample/?dbmrglobal-cancer-di
agnostics-market
3
Market Segmentation
The market is segmented on the basis of
technology and application, and geography. The
global cancer diagnostics market, by technology,
is categorized into two main segmentsplatform
based and instrument-based. The global cancer
diagnostics market, by application into lung
cancer, breast cancer, colorectal cancer,
melanoma and other forms of cancer. Breast cancer
diagnosis is expected to hold the largest share
of this market in 2015, due to very high
prevalence in North America also due to very high
cost of mammography instruments.
Request for Customization _at_ sales_at_databridgemarke
tresearch.com
4
Regional Analysis

• Based on geography the market is segmented into 5
  geographical regions,
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa.
• The geographical regions are further segmented
  into 29 major countries such as U.S. Canada,
  Mexico, Germany, France, U.K., Belgium,
  Switzerland, Belgium, Turkey, Japan, China,
  Singapore, Brazil, India, Russia, South Africa
  and others.

5
Major Key Players

• Major players in the Global Cancer Diagnostics
  Market are
• Abbott Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Becton, Dickinson and Company
• GE Healthcare
• QIAGEN N.V.
• Agilent Technologies, Inc.
• Roche Diagnostics
• Siemens Healthcare
• Philips Healthcare, and C.R. Bard, Inc., Hologic,
  Inc. among other players.

http//databridgemarketresearch.com/inquire-before
-buying/?dbmrglobal-cancer-diagnostics-market
6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Ankit Singh1-888-387-2818 (Toll
Free) sales_at_databridgemarketresearch.com